1 - 25 of 94 results for author:"Ihle J.N." in Literature citations
Results Customize
› Repeat search in UniProtKB (67)
| An early onset progressive motor neuron disorder in Scyl1-deficient mice is associated with mislocalization of TDP-43. Pelletier S., Gingras S., Howell S., Vogel P., Ihle J.N. J. Neurosci. 32:16560-16573(2012) · Mapped (10) |
| Chromatin condensation via the condensin II complex is required for peripheral T-cell quiescence. Rawlings J.S., Gatzka M., Thomas P.G., Ihle J.N. EMBO J. 30:263-276(2011) · Mapped (15) |
| Ars2 links the nuclear cap-binding complex to RNA interference and cell proliferation. Gruber J.J., Zatechka D.S., Sabin L.R., Yong J., Lum J.J., Kong M., Zong W.-X., Zhang Z., Lau C.-K., Rawlings J. et al. |
| Negative regulation of Jak2 by its auto-phosphorylation at tyrosine 913 via the Epo signaling pathway. Funakoshi-Tago M., Tago K., Kasahara T., Parganas E., Ihle J.N. Cell. Signal. 20:1995-2001(2008) · Mapped (3) |
| Leukemia inhibitory factor regulates trophoblast giant cell differentiation via Janus kinase 1-signal transducer and activator of transcription 3-suppressor of cytokine signaling 3 pathway. Takahashi Y., Takahashi M., Carpino N., Jou S.T., Chao J.R., Tanaka S., Shigeyoshi Y., Parganas E., Ihle J.N. Mol. Endocrinol. 22:1673-1681(2008) · Mapped (22) |
| Hax1-mediated processing of HtrA2 by Parl allows survival of lymphocytes and neurons. Chao J.R., Parganas E., Boyd K., Hong C.Y., Opferman J.T., Ihle J.N. |
| Jak2 FERM domain interaction with the erythropoietin receptor regulates Jak2 kinase activity. Funakoshi-Tago M., Pelletier S., Moritake H., Parganas E., Ihle J.N. Mol. Cell. Biol. 28:1792-1801(2008) · Mapped (3) |
| Characterization of a family of novel cysteine- serine-rich nuclear proteins (CSRNP). Gingras S., Pelletier S., Boyd K., Ihle J.N. |
| Jak2: normal function and role in hematopoietic disorders. Ihle J.N., Gilliland D.G. Curr. Opin. Genet. Dev. 17:8-14(2007) · UniProtKB (1) |
| Receptor specific downregulation of cytokine signaling by autophosphorylation in the FERM domain of Jak2. Funakoshi-Tago M., Pelletier S., Matsuda T., Parganas E., Ihle J.N. |
| Two domains of the erythropoietin receptor are sufficient for Jak2 binding/activation and function. Pelletier S., Gingras S., Funakoshi-Tago M., Howell S., Ihle J.N. Mol. Cell. Biol. 26:8527-8538(2006) · Mapped (7) |
| A role for STAT5A/B in protection of peripheral T-lymphocytes from postactivation apoptosis: insights from gene expression profiling. Gatzka M., Piekorz R., Moriggl R., Rawlings J., Ihle J.N. Cytokine 34:143-154(2006) · Mapped (9) |
| Trophoblast stem cells rescue placental defect in SOCS3-deficient mice. Takahashi Y., Dominici M., Swift J., Nagy C., Ihle J.N. J. Biol. Chem. 281:11444-11445(2006) · Mapped (2) |
| Role of erythropoietin receptor signaling in Friend virus-induced erythroblastosis and polycythemia. Zhang J., Randall M.S., Loyd M.R., Li W., Schweers R.L., Persons D.A., Rehg J.E., Noguchi C.T., Ihle J.N., Ney P.A. Blood 107:73-78(2006) · Mapped (11) |
| Evi-1 expression in Xenopus. Mead P.E., Parganas E., Ohtsuka S., Morishita K., Gamer L., Kuliyev E., Wright C.V., Ihle J.N. Gene Expr. Patterns 5:601-608(2005) · UniProtKB (1) |
| Stat5 tetramer formation is associated with leukemogenesis. Moriggl R., Sexl V., Kenner L., Duntsch C., Stangl K., Gingras S., Hoffmeyer A., Bauer A., Piekorz R., Wang D. et al. Cancer Cell 7:87-99(2005) · Mapped (14) |
| Re-examination of the role of suppressor of cytokine signaling 1 (SOCS1) in the regulation of toll-like receptor signaling. Gingras S., Parganas E., de Pauw A., Ihle J.N., Murray P.J. J. Biol. Chem. 279:54702-54707(2004) · Mapped (21) |
| Regulation of progesterone levels during pregnancy and parturition by signal transducer and activator of transcription 5 and 20alpha-hydroxysteroid dehydrogenase. Piekorz R.P., Gingras S., Hoffmeyer A., Ihle J.N., Weinstein Y. Mol. Endocrinol. 19:431-440(2005) · Mapped (11) |
| The centrosomal, putative tumor suppressor protein TACC2 is dispensable for normal development, and deficiency does not lead to cancer. Schuendeln M.M., Piekorz R.P., Wichmann C., Lee Y., McKinnon P.J., Boyd K., Takahashi Y., Ihle J.N. Mol. Cell. Biol. 24:6403-6409(2004) · UniProtKB (1) · Mapped (19) |
| Absence of an essential role for thymic stromal lymphopoietin receptor in murine B-cell development. Carpino N., Thierfelder W.E., Chang M.S., Saris C., Turner S.J., Ziegler S.F., Ihle J.N. Mol. Cell. Biol. 24:2584-2592(2004) · Mapped (4) |
| Regulation of ZAP-70 activation and TCR signaling by two related proteins, Sts-1 and Sts-2. Carpino N., Turner S., Mekala D., Takahashi Y., Zang H., Geiger T.L., Doherty P., Ihle J.N. |
| Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Jeffers J.R., Parganas E., Lee Y., Yang C., Wang J., Brennan J., MacLean K.H., Han J., Chittenden T., Ihle J.N. et al. Cancer Cell 4:321-328(2003) · Mapped (18) |
| SOCS3 regulates the plasticity of gp130 signaling. Lang R., Pauleau A.L., Parganas E., Takahashi Y., Mages J., Ihle J.N., Rutschman R., Murray P.J. Nat. Immunol. 4:546-550(2003) · Mapped (6) |
| Jak1 deficiency leads to enhanced Abelson-induced B-cell tumor formation. Sexl V., Kovacic B., Piekorz R., Moriggl R., Stoiber D., Hoffmeyer A., Liebminger R., Kudlacek O., Weisz E., Rothammer K. et al. Blood 101:4937-4943(2003) · Mapped (8) |
| SOCS3: an essential regulator of LIF receptor signaling in trophoblast giant cell differentiation. Takahashi Y., Carpino N., Cross J.C., Torres M., Parganas E., Ihle J.N. EMBO J. 22:372-384(2003) · Mapped (5) |